Regional Media

Clear 74°. Wind: N 0 mph.
Loading advertisement…
Trending: A forced-labor crackdown or an end-run around Congress? Dissecting Trump’s new tariffs
HomeNewsNationalHealth ( Page 89)

Health

Subscribe to the Health News Feed.
SHARE NOW
by

Purdue Pharma dissolves in bankruptcy, names board of nonprofit successor

By Dietrich Knauth NEW YORK, May 1 (Reuters) - Purdue Pharma said on Friday that it has ceased operations and concluded its bankruptcy, re-emerging as a nonprofit focused on treating opioid addiction, overseen by a new board with government and health industry experience. Purdue, which ...
by

Canada approves second generic version of Ozempic

OTTAWA, May 1 (Reuters) - The Canadian health regulator said on Friday that it had approved Canada-based Apotex's generic version of semaglutide, making it the second copycat version of Danish drugmaker Novo Nordisk's blockbuster diabetes drug Ozempic authorized in the country. (Reporting by Ismail ...
by

US court blocks mail-order access to abortion drugs, for now

By Daniel Wiessner May 1 (Reuters) - A U.S. appeals court on Friday temporarily blocked a federal rule allowing the abortion drug mifepristone to be dispensed through the mail, significantly curtailing access to the drug nationwide and particularly in states that have banned abortion. A ...
by

Trump says U.S. to provide GLP-1 drugs for Medicare patients

THE VILLAGES, Florida, May 1 (Reuters) - U.S. President Donald Trump said on Friday the government is moving to make GLP-1 weight-loss and diabetes drugs available to seniors enrolled in Medicare from July 1. (Reporting By Jarrett Renshaw; editing by Michelle Nichols ) Brought to you ...
by

Court restricts abortion access across the US by blocking the mailing of mifepristone

A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking mailing of mifepristone prescriptions. Friday's unanimous ruling from a three-judge panel of the New Orleans-based 5th U.S. Circuit Court of Appeals is requiring that ...
by

FDA approves 1st non-antipsychotic medication for agitation in Alzheimer’s disease

(NEW YORK) -- The Food and Drug Administration (FDA) approved the drug Auvelity this week for the treatment of agitation in adults with Alzheimer's dementia.The extended-release tablet is the first FDA-approved medication for this condition that is not an anti-psychotic.Anti-psychotics carry serious risks including ...
Loading advertisement…
by

After nearly 1,000 cases, here’s how South Carolina officials beat back a measles outbreak

(NEW YORK) -- A few months ago, a measles outbreak seemed poised to overwhelm the northern region of South Carolina.More than 100 infections were being reported every week, with the total eventually surpassing that of last year's record-setting outbreak in Texas.However, after six months ...
by

OxyContin maker Purdue Pharma’s settlement, by the numbers

OxyContin maker Purdue Pharma is set to dissolve and be replaced with a new company operating in the public interest under the settlement of thousands of lawsuits that goes into effect Friday. It's among the largest in a series of settlements over the toll of ...
by

Big Pharma M&A set for mega year as patent expiries drive deal urgency

By Christy Santhosh and Sriparna Roy May 1 (Reuters) - Biotech dealmaking is on pace for a bumper year in 2026, with large drugmakers on an acquisition spree to boost their pipelines ahead of upcoming patent losses. The surge appears broader and more durable than just ...
by

Peltz’s Trian urges Solventum to rightsize costs, divest non-core businesses

April 30 (Reuters) - Nelson Peltz's Trian Fund Management on Thursday called on Solventum to rightsize overhead costs, divest non-core businesses and improve capital allocation in its latest appeal for a performance turnaround at the medical device maker. Over the last 18 months, Trian, which ...
by

Moderna tops revenue estimates on stronger international COVID vaccine sales

By Julie Steenhuysen and Siddhi Mahatole May 1 (Reuters) - Moderna surpassed Wall Street estimates for first-quarter revenue on Friday, helped by better-than-expected sales of its COVID-19 vaccine in international markets, sending its shares up nearly 8% in premarket trading. International revenue came in at $311 ...
by

Lilly’s obesity pill hits nearly 6,000 prescriptions in third week after launch

By Christy Santhosh May 1 (Reuters) - Eli Lilly's newly launched oral weight-loss drug, Foundayo, was prescribed 5,612 times in the U.S. in the third week after its launch, according to analysts citing IQVIA data. The pill, launched in April, has seen a modest uptake so ...
First Previous858687888990919293Next Last